Literature DB >> 15300571

The quality of published health economic analyses in digestive diseases: a systematic review and quantitative appraisal.

Brennan M R Spiegel1, Laura E Targownik, Fasiha Kanwal, Vincent Derosa, Gareth S Dulai, Ian M Gralnek, Chiun-Fang Chiou.   

Abstract

BACKGROUND & AIMS: Health economic analyses are increasingly common in the digestive diseases literature and often are cited to frame practice guidelines. Although clinical trials are subjected routinely to critical appraisal, there has been no attempt to appraise the quality of health economic analyses with a validated instrument. We sought to appraise the quality of health economic analyses in digestive diseases, and to identify predictors of study quality.
METHODS: We performed a systematic review to identify digestive disease health economic analyses published since 1980. We assessed these studies using the Quality of Health Economic Studies (QHES), a validated quality-scoring instrument (score range = 0-100; >75 = high quality). We conducted regression analysis to identify predictors of high quality.
RESULTS: Of 186 identified analyses, 29% were high quality, 71% failed to address potential model biases, 52% failed to disclose conflicts of interest, and 74% failed to describe methods for deriving the model assumptions. Four factors predicted high quality in logistic regression: (1) one or more authors had an advanced degree in health services or a related field (odds ratio for high quality, 5.0; 95% confidence interval, 2.6-9.3); (2) the study used decision-analysis software package (odds ratio, 2.4; 95% confidence interval, 1.2-4.7); (3) the study was federally funded (odds ratio, 2.2; 95% confidence interval, 1.2-4.1); and (4) the study cited the National Panel on Cost Effectiveness guidelines (odds ratio, 2.1; 95% confidence interval, 1.1-4.2).
CONCLUSIONS: Less than one third of health economic analyses in digestive diseases meet criteria for high quality. Study quality is limited by factors that potentially can be remedied. These data may be used to focus the attention of journal editors and peer reviewers to ensure the future high quality of health economic analyses in digestive diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15300571     DOI: 10.1053/j.gastro.2004.04.020

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  The cost-effectiveness of drug-eluting stents: a systematic review.

Authors:  Suzanne Ligthart; Floortje Vlemmix; Nandini Dendukuri; James M Brophy
Journal:  CMAJ       Date:  2006-12-19       Impact factor: 8.262

Review 2.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

3.  Transparency in economic evaluations.

Authors:  Suzanne Hill
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Methodological reviews of economic evaluations in health care: what do they target?

Authors:  Maria-Florencia Hutter; Roberto Rodríguez-Ibeas; Fernando Antonanzas
Journal:  Eur J Health Econ       Date:  2013-08-24

Review 5.  Current status of cost utility analyses in total joint arthroplasty: a systematic review.

Authors:  Benedict U Nwachukwu; Kevin J Bozic; William W Schairer; Jaime L Bernstein; David S Jevsevar; Robert G Marx; Douglas E Padgett
Journal:  Clin Orthop Relat Res       Date:  2014-09-30       Impact factor: 4.176

6.  ECONOMIC EVALUATIONS OF INTERVENTIONS FOR TRANSTIBIAL AMPUTEES: A SCOPING REVIEW OF COMPARATIVE STUDIES.

Authors:  M Jason Highsmith; Jason T Kahle; Amanda Lewandowski; Tyler D Klenow; John J Orriola; Rebecca M Miro; Owen T Hill; Sylvia Ursula Raschke; Michael S Orendurff; James T Highsmith; Bryce S Sutton
Journal:  Technol Innov       Date:  2016-09-01

Review 7.  A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.

Authors:  Ifigeneia Mavranezouli; Joran Lokkerbol
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

Review 8.  The quality of pharmacoeconomic evaluations of age-related macular degeneration therapeutics: a systematic review and quantitative appraisal of the evidence.

Authors:  William J Foster; Waqas Tufail; Amalia M Issa
Journal:  Br J Ophthalmol       Date:  2010-09       Impact factor: 4.638

Review 9.  Health Outcomes and Costs of Social Work Services: A Systematic Review.

Authors:  Gail Steketee; Abigail M Ross; Madeline K Wachman
Journal:  Am J Public Health       Date:  2017-12       Impact factor: 9.308

10.  A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example.

Authors:  Tjeerd-Pieter van Staa; Hubert G Leufkens; Bill Zhang; Liam Smeeth
Journal:  PLoS Med       Date:  2009-12-08       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.